BAX INVESTORS: Baxter International Inc. Investors are Notified of the Pending Securities Class Action and are Urged to Contact BFA Law before Court Deadline
Article excerpt
BAX INVESTORS: Baxter International Inc. investors are notified of the pending securities class action and are urged to contact BFA law before court deadline. October 23, 2025 7:18 AM EDT | source: Bleichmar Fonti & Auld. New York, New York-(Newsfile Corp. - October 23, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Baxter International Inc. (NYSE: BAX) and certain of the Company's senior executives for securities fraud after significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Baxter, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/baxter-international-inc-class-action. Investors have until December 15, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Baxter common stock. The case is pending in the U.S. District Court for the Northern District of Illinois and is captioned Electrical Workers Pension Fund, Local 103, I.B.E.W. v. Baxter International Inc., et al., No. 1:25-cv-12672. Why Was Baxter Sued Under the Federal Securities Laws? Baxter manufactures medical devices. One of the Company's most important growth drivers is its Novum IQ Large Volume pump...
Keep reading with a free account
The rest of this article, and every signal for Baxter, is in your free account.
Extracted from this sentence
In 2020, Baxter launched the Novum LVP in Canada while its application for FDA approval in the U.S. was pending.